These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 22248858)
21. Novel compounds to combat trypanosomatid infections: a medicinal chemical perspective. González M; Cerecetto H Expert Opin Ther Pat; 2011 May; 21(5):699-715. PubMed ID: 21428846 [TBL] [Abstract][Full Text] [Related]
22. N,N'-Bisbenzylidenebenzene-1,4-diamines and N,N'-Bisbenzylidenenaphthalene-1,4-diamines as Sirtuin Type 2 (SIRT2) Inhibitors. Kiviranta PH; Leppänen J; Kyrylenko S; Salo HS; Lahtela-Kakkonen M; Tervo AJ; Wittekindt C; Suuronen T; Kuusisto E; Järvinen T; Salminen A; Poso A; Wallén EA J Med Chem; 2006 Dec; 49(26):7907-11. PubMed ID: 17181175 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of 1-amino-1,1-bisphosphonates derived from fatty acids against Trypanosoma cruzi targeting farnesyl pyrophosphate synthase. Szajnman SH; Ravaschino EL; Docampo R; Rodriguez JB Bioorg Med Chem Lett; 2005 Nov; 15(21):4685-90. PubMed ID: 16143525 [TBL] [Abstract][Full Text] [Related]
24. Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites. Urbina JA Parasitology; 1997; 114 Suppl():S91-9. PubMed ID: 9309771 [TBL] [Abstract][Full Text] [Related]
25. Toward a Drug Against All Kinetoplastids: From LeishBox to Specific and Potent Trypanothione Reductase Inhibitors. Ilari A; Genovese I; Fiorillo F; Battista T; De Ionna I; Fiorillo A; Colotti G Mol Pharm; 2018 Aug; 15(8):3069-3078. PubMed ID: 29897765 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines. Hui X; Desrivot J; Bories C; Loiseau PM; Franck X; Hocquemiller R; Figadère B Bioorg Med Chem Lett; 2006 Feb; 16(4):815-20. PubMed ID: 16309903 [TBL] [Abstract][Full Text] [Related]
28. An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases. Kourbeli V; Chontzopoulou E; Moschovou K; Pavlos D; Mavromoustakos T; Papanastasiou IP Molecules; 2021 Jul; 26(15):. PubMed ID: 34361781 [TBL] [Abstract][Full Text] [Related]
29. SAR studies on azasterols as potential anti-trypanosomal and anti-leishmanial agents. Gigante F; Kaiser M; Brun R; Gilbert IH Bioorg Med Chem; 2009 Aug; 17(16):5950-61. PubMed ID: 19620005 [TBL] [Abstract][Full Text] [Related]
30. Diamidines as antitrypanosomal, antileishmanial and antimalarial agents. Werbovetz K Curr Opin Investig Drugs; 2006 Feb; 7(2):147-57. PubMed ID: 16499285 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines. Sunduru N; Nishi ; Palne S; Chauhan PM; Gupta S Eur J Med Chem; 2009 Jun; 44(6):2473-81. PubMed ID: 19217698 [TBL] [Abstract][Full Text] [Related]
32. Selective antimicrotubule activity of N1-phenyl-3,5-dinitro-N4,N4-di-n-propylsulfanilamide (GB-II-5) against kinetoplastid parasites. Werbovetz KA; Sackett DL; Delfín D; Bhattacharya G; Salem M; Obrzut T; Rattendi D; Bacchi C Mol Pharmacol; 2003 Dec; 64(6):1325-33. PubMed ID: 14645662 [TBL] [Abstract][Full Text] [Related]
33. Diamine and aminoalcohol derivatives active against Trypanosoma brucei. Olmo ED; Diaz-González R; Escarcena R; Carvalho L; Bustos LA; Navarro M; Feliciano AS Bioorg Med Chem Lett; 2012 Jan; 22(1):440-3. PubMed ID: 22119463 [TBL] [Abstract][Full Text] [Related]
34. Synthesis, structural elucidation and in vitro antiparasitic activity against Trypanosoma cruzi and Leishmania chagasi parasites of novel tetrahydro-1-benzazepine derivatives. Gómez-Ayala S; Castrillón JA; Palma A; Leal SM; Escobar P; Bahsas A Bioorg Med Chem; 2010 Jul; 18(13):4721-39. PubMed ID: 20627590 [TBL] [Abstract][Full Text] [Related]
35. Leishmanicidal activity of some aliphatic diamines and amino-alcohols. del Olmo E; Alves M; López JL; Inchaustti A; Yaluff G; Rojas de Arias A; San Feliciano A Bioorg Med Chem Lett; 2002 Feb; 12(4):659-62. PubMed ID: 11844694 [TBL] [Abstract][Full Text] [Related]
36. Polyamine-based analogs and conjugates as antikinetoplastid agents. Jagu E; Pomel S; Pethe S; Loiseau PM; Labruère R Eur J Med Chem; 2017 Oct; 139():982-1015. PubMed ID: 28886510 [TBL] [Abstract][Full Text] [Related]
37. VFV as a New Effective CYP51 Structure-Derived Drug Candidate for Chagas Disease and Visceral Leishmaniasis. Lepesheva GI; Hargrove TY; Rachakonda G; Wawrzak Z; Pomel S; Cojean S; Nde PN; Nes WD; Locuson CW; Calcutt MW; Waterman MR; Daniels JS; Loiseau PM; Villalta F J Infect Dis; 2015 Nov; 212(9):1439-48. PubMed ID: 25883390 [TBL] [Abstract][Full Text] [Related]
38. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs. Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238 [TBL] [Abstract][Full Text] [Related]